208 related articles for article (PubMed ID: 3649316)
1. Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences.
Heinrich D; Sugg U; Brackmann HH; Stephan W; Lissner R
Dev Biol Stand; 1987; 67():311-7. PubMed ID: 3649316
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of the hepatitis safety of a beta-propiolactone/ultraviolet treated factor IX concentrate (PPSB).
Heinrich D; Kotitschke R; Berthold H
Thromb Res; 1982 Oct; 28(1):75-83. PubMed ID: 7157232
[TBL] [Abstract][Full Text] [Related]
3. [Inactivation of hepatitis non-A, non-B virus in intravenous immunoglobulins by beta-propiolactone].
Dichtelmüller H; Stephan W; Prince AM; Brotman B
Beitr Infusionsther; 1988; 21():202-4. PubMed ID: 2462976
[No Abstract] [Full Text] [Related]
4. Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, beta-propiolactone, and ultraviolet irradiation.
Prince AM; Stephan W; Kotitschke R; Brotman B
Thromb Haemost; 1983 Aug; 50(2):534-6. PubMed ID: 6415846
[TBL] [Abstract][Full Text] [Related]
5. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients.
Heimburger N; Karges HE; Weidmann E
Dev Biol Stand; 1987; 67():303-10. PubMed ID: 3038638
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of hepatitis viruses and HIV in plasma and plasma derivatives by treatment with beta-propiolactone/UV irradiation.
Stephan W
Curr Stud Hematol Blood Transfus; 1989; (56):122-7. PubMed ID: 2642784
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of betapropiolactone/ultraviolet irradiation (BPL/UV) treatment of source plasma on hepatitis transmission by factor IX complex in chimpanzees.
Prince AM; Stephan W; Brotman B; van den Ende MC
Thromb Haemost; 1980 Dec; 44(3):138-42. PubMed ID: 7466740
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the Hutchinson strain of non-A, non-B hepatitis virus by combined use of beta-propiolactone and ultraviolet irradiation.
Prince AM; Stephan W; Dichtelmüller H; Brotman B; Huima T
J Med Virol; 1985 Jun; 16(2):119-25. PubMed ID: 3925077
[TBL] [Abstract][Full Text] [Related]
9. Long-term tolerance and recovery of beta-propiolactone/ultraviolet (beta PL/UV) treated PPSB in chimpanzees.
Stephan W; Kotitschke R; Prince AM; Brotman B
Thromb Haemost; 1981 Aug; 46(2):511-4. PubMed ID: 7302890
[TBL] [Abstract][Full Text] [Related]
10. Clinical studies with treated clotting factor concentrates.
Colombo M; Mannucci PM
Dev Biol Stand; 1987; 67():333-6. PubMed ID: 3038639
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined treatment of serum containing hepatitis B virus with beta-propiolactone and ultraviolet irradiation.
Stephan W; Berthold H; Prince AM
Vox Sang; 1981 Sep; 41(3):134-8. PubMed ID: 7331286
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.
Parquet A; Boneu B; Bosser C; Cazenave JP; Dirat G; Gazengel G; Grunebaum L; Sultan Y; Verroust F; Wiesel ML
Nouv Rev Fr Hematol (1978); 1988; 30(4):205-7. PubMed ID: 3143099
[TBL] [Abstract][Full Text] [Related]
13. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX
Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827
[TBL] [Abstract][Full Text] [Related]
14. Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate.
Prince AM; Horowitz B; Brotman B
Lancet; 1986 Mar; 1(8483):706-10. PubMed ID: 2870224
[TBL] [Abstract][Full Text] [Related]
15. Factor VIII concentrate from cold sterilized human plasma.
Stephan W; Prince AM; Kotitschke R
Dev Biol Stand; 1983; 54():491-5. PubMed ID: 6418593
[TBL] [Abstract][Full Text] [Related]
16. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P
Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of HTLV-III/LAV, hepatitis B and non-A/non-B viruses by pasteurization in human plasma protein preparations.
Mauler R; Merkle W; Hilfenhaus J
Dev Biol Stand; 1987; 67():337-51. PubMed ID: 3111911
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the Hutchinson strain of hepatitis non-A, non-B virus in intravenous immunoglobulin by beta-propiolactone.
Stephan W; Dichtelmüller H; Prince AM; Brotman B; Huima T
J Med Virol; 1988 Nov; 26(3):227-32. PubMed ID: 3144576
[TBL] [Abstract][Full Text] [Related]
19. Beta-propiolactone for the inactivation of non-A/non-B type 1 hepatitis virus capable of inducing cytoplasmic tubular ultrastructures in chimpanzees.
Yoshizawa H; Itoh Y; Iwakiri S; Kitajima K; Noguchi Y; Tachibana K; Nakamura T; Miyakawa Y; Mayumi M
Vox Sang; 1984; 46(2):86-91. PubMed ID: 6422638
[TBL] [Abstract][Full Text] [Related]
20. Current safety of clotting factor concentrates.
Epstein JS; Fricke WA
Arch Pathol Lab Med; 1990 Mar; 114(3):335-40. PubMed ID: 2407224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
